The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Background Preeclampsia is a life-threatening disease in pregnancy, and its complex pathomechanisms are poorly understood. In preeclampsia, lipid metabolism is substantially altered. In late onset preeclampsia, remnant removal disease like lipoprotein profiles have been observed. Lipid apheresis is currently being explored as a possible therapeutic approach to prolong preeclamptic pregnancies. Here,...
Preeclampsia (PE) and IUGR share common pathomechanisms. Recently, we reported on serum lipid concentrations in both conditions in the early-onset form of PE before 34 weeks of gestation (Pecks et al., 2012). Subtle changes of triglyceride concentrations were noticed in PE while a significant decrease in LDL levels was found in IUGR subjects when compared to a control group (CTRL). We now aimed to...
Alterations in lipoprotein metabolism have been proposed as a possible pathophysiologic factor for preeclampsia. Elevation of very low density lipoproteins (VLDL) and predominance of atherogenic small dense low density lipoproteins (sdLDL) have been demonstrated in preeclampsia. Heparin-mediated-extracorporeal-LDL-precipitation (H.E.L.P.)-apheresis is an established method for lipoprotein removal...
Preeclampsia is a life-threatening disorder of late gestation of unknown origin. Soluble fms-like tyrosine kinase 1 (sFlt-1) is discussed as marker, but also as pathogenic factor for preeclampsia. Thus, removal of sFlt-1 by dextran-sulfate apheresis is suggested to be causative for clinical improvements in preeclampsia. However, as shown by Wang et al. (2006) heparin-mediated extracorporeal low-density...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.